🏥 治験ポータル

← 治験一覧に戻る

3血管血流予備量比（FFR）の臨床的意義

基本情報

NCT ID: NCT01621438
ステータス: 不明
試験のフェーズ: -
試験タイプ: 観察
目標被験者数: 1,136
治験依頼者名: Seoul National University Hospital

概要

This study will evaluate the influence of total atherosclerotic burden assessed by 3-vessel fractional flow reserve (FFR) on the clinical outcomes of the patients with multi-vessel disease. For this purpose, the clinical data of the patients with 3-vessel intermediate coronary artery disease, whose FFR was measured at all 3-vessels due to their own clinical needs, will be analyzed.

対象疾患

Multivessel Coronary Artery Disease

依頼者（Sponsor）

Queen Mary Hospital, Hong Kong(OTHER)

Gifu Heart Center(OTHER)

Kokura Memorial Hospital(OTHER)

Inje University(OTHER)

Wakayama Medical University(OTHER)

Samsung Medical Center(OTHER)

Fu Wai Hospital, Beijing, China(OTHER)

Keimyung University Dongsan Medical Center(OTHER)

Ulsan University Hospital(OTHER)

The First Affiliated Hospital With Nanjing Medical University(OTHER)

Ajou University School Of Medicine(OTHER)

Guangdong Provincial People's Hospital(OTHER)

Seoul National University Hospital(OTHER)

National University Heart Centre, Singapore(OTHER)

Aichi Medical University(OTHER)

Tokyo Medical College Hospital, Japan(UNKNOWN)

National Taiwan University Hospital(OTHER)

Second Affiliated Hospital, School Of Medicine, Zhejiang University(OTHER)

Nagoya Daini Nesseki Hospital(OTHER)

United Christian Hospital(OTHER)

実施施設 (6)

愛知医科大学病院

Nagakute, Japan

小倉記念病院

Kitakyushu, Japan

Wakayama medical university

Wakayama, Japan

岐阜ハートセンター

Gifu, Japan

2nd Red Cross hospital

Kyoto, Japan

東京歯科大学水道橋病院

Tokyo, Japan